WilmerHale represented Epizyme Inc. in its follow-on offering announced on January 12, 2016.
The WilmerHale team was led by Partner Stuart Falber and included Partner Bruce Manheim, Counsel Carolyn Rucci and Associate Julie Fogarty.
Further details can be found in Epizyme's press release announcing the closing of the transaction.
We appreciate your interest in WilmerHale. While we are pleased to have you contact us, please keep in mind that merely contacting WilmerHale does not create an attorney-client relationship. Such a relationship will not arise until the Firm agrees in writing to represent you in connection with a particular matter. Importantly, unless and until this has occurred, you should not provide us with any confidential information, and we have no duty to keep confidential any information that we may receive from you. Thank you for your understanding.
